Literature DB >> 21911704

Lack of response to monoclonal antibody therapy in neuromyelitis optica.

Peiqing Qian, Anne H Cross, Robert T Naismith.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21911704      PMCID： PMC3495590          DOI： 10.1001/archneurol.2011.194

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  7 in total

1.  Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica.

Authors:  Marcelo Matiello; Sean J Pittock; Luis Porrata; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2011-03-14

2.  Neuromyelitis optica: clinical predictors of a relapsing course and survival.

Authors:  Dean M Wingerchuk; Brian G Weinshenker
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

3.  Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

Authors:  Bianca Weinstock-Guttman; Murali Ramanathan; Norah Lincoff; Salvatore Q Napoli; Jitendra Sharma; Joan Feichter; Rohit Bakshi
Journal:  Arch Neurol       Date:  2006-07

4.  Neuromyelitis optica treatment: analysis of 36 patients.

Authors:  Denis Bernardi Bichuetti; Enedina Maria Lobato de Oliveira; Daniel May Oliveira; Nilton Amorin de Souza; Alberto Alain Gabbai
Journal:  Arch Neurol       Date:  2010-09

5.  Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.

Authors:  Su-Hyun Kim; Woojun Kim; Min Su Park; Eun Hee Sohn; Xue Feng Li; Ho Jin Kim
Journal:  Arch Neurol       Date:  2010-12-13

6.  Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.

Authors:  Anu Jacob; Brian G Weinshenker; Ivo Violich; Nancy McLinskey; Lauren Krupp; Robert J Fox; Dean M Wingerchuk; Mike Boggild; Cris S Constantinescu; Aaron Miller; Tracy De Angelis; Marcelo Matiello; Bruce A C Cree
Journal:  Arch Neurol       Date:  2008-09-08

7.  Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Authors:  Alasdair J Coles; D Alastair S Compston; Krzysztof W Selmaj; Stephen L Lake; Susan Moran; David H Margolin; Kim Norris; P K Tandon
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245
  7 in total
  5 in total

1.  Practice current: How do you treat neuromyelitis optica?

Authors:  Aravind Ganesh
Journal:  Neurol Clin Pract       Date:  2017-04

Review 2.  Update on neuromyelitis optica: natural history and management.

Authors:  Panitha Jindahra; T Plant
Journal:  Eye Brain       Date:  2012-03-26

Review 3.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 4.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 5.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.